RT Journal Article
SR Electronic
T1 Nationwide melanoma registry databases in real-world settings: a scoping review protocol
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.28.24311481
DO 10.1101/2024.08.28.24311481
A1 Yang, Songchun
A1 Deng, Dilan
A1 Lin, Wenrui
A1 Chen, Xiaozhen
A1 Zhao, Shuang
A1 Lu, Lixia
A1 Xiao, Yi
A1 Shen, Minxue
A1 Chen, Mingliang
A1 Chen, Xiang
A1 Su, Juan
YR 2024
UL http://medrxiv.org/content/early/2024/08/29/2024.08.28.24311481.abstract
AB Introduction A patient registry database is an important tool to address a wide range of research questions. Several countries have established nationwide melanoma registry databases. However, there is no report on summarising and comparing these databases. This scoping review aims to answer a broad question on how contemporary nationwide melanoma registry databases were conducted across different countries.Methods The proposed scoping review will follow the guidelines described by the Joanna Briggs Institute manual for evidence synthesis and results will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis extension for Scoping Reviews guideline. PubMed, Embase, Web of Science, ClinicalTrials.gov, and Google will be parallelly and independently searched by two reviewers. We will include nationwide melanoma databases with the aim of continuously and systematically collecting medical records and other relevant information about melanoma patients under routine conditions. The reference list of all included publications will also be screened for additional literature. The literature search will be limited to records after the year 2000 and in English. Two reviewers will independently review the selected literature for information extraction according to a predefined extraction guidance sheet. For databases without relevant literature introductions, we will try contacting the main researchers of the database via email for detailed information. We will provide a brief descriptive analysis of the collected data.Expected results and implications This scoping review will provide an extensive description of how contemporary nationwide melanoma databases were conducted. Findings have the potential to enhance the understanding of melanoma registry databases among researchers in related fields and promote subsequent international collaborations that aim at promoting the clinical practice of melanoma.STRENGTHS AND LIMITATIONS OF THIS STUDY➢ This is the first scoping review protocol of summarizing contemporary nationwide melanoma databases globally.➢ Targeted online surveys through email enable us to have a more comprehensive understanding of the latest situation of current databases.➢ We expect to answer a broad question on how contemporary nationwide melanoma registry databases were conducted across different countries.➢ Potentially missing relevant databases that have not been insufficiently reported is a limitation of the present scoping review.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Key Research and Development Program of China (2022YFC2504700) and the National Natural Science Foundation of China (grant No. 81974478, 82173009). These funders have not supported the research work required for the preparation of this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors